174
Participants
Start Date
April 5, 2019
Primary Completion Date
October 25, 2019
Study Completion Date
October 25, 2019
XEN Group
Chart review was conducted in participants with open angle glaucoma who underwent placement of the implant XEN 45 Gel Stent as a standalone procedure from 1 January 2014 to 1 October 2015.
Phacoemulsification
Chart review was conducted in participants with open angle glaucoma who underwent placement of the implant XEN 45 Gel Stent in combination with phacoemulsification (Phaco) from 1 January 2014 to 1 October 2015.
Clinical Trials Registry Team, Irvine
Lead Sponsor
Allergan
INDUSTRY